OccamzRazor
New York
About OccamzRazor
OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.) and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: occamzrazor.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/occamzrazor-57623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.